Mortality from sepsis among patients with schizophrenia and mood disorders in an intensive care unit: A chart review

Takuto Ishida; Kazuha Nakamura; Kazuki Miyazaki; Takahiro Yukawa; Toshinobu Yamagishi; Kazuhiro Sugiyama; Takahiro Tanabe; Yuichi Hamabe; Masaru Mimura; Takefumi Suzuki; Hiroyuki Uchida

doi:10.1016/j.psychres.2018.12.061

Mortality from sepsis among patients with schizophrenia and mood disorders in an intensive care unit: A chart review

Takuto Ishida, Kazuha Nakamura, Kazuki Miyazaki, Takahiro Yukawa, Toshinobu Yamagishi, Kazuhiro Sugiyama, Takahiro Tanabe, Yuichi Hamabe, Masaru Mimura, Takefumi Suzuki, Hiroyuki Uchida

Department of Psychiatry

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	372-373
Number of pages	2
Journal	Psychiatry Research
Volume	279
DOIs	https://doi.org/10.1016/j.psychres.2018.12.061
Publication status	Published - 2019 Sept

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.psychres.2018.12.061

Cite this

@article{0c8be84eadc441489ea237fb5c9089eb,

title = "Mortality from sepsis among patients with schizophrenia and mood disorders in an intensive care unit: A chart review",

author = "Takuto Ishida and Kazuha Nakamura and Kazuki Miyazaki and Takahiro Yukawa and Toshinobu Yamagishi and Kazuhiro Sugiyama and Takahiro Tanabe and Yuichi Hamabe and Masaru Mimura and Takefumi Suzuki and Hiroyuki Uchida",

note = "Funding Information: Dr. Uchida has received grants from Eisai, Otsuka Pharmaceutical, Dainippon-Sumitomo Pharma, Mochida Pharmaceutical, Meiji-Seika Pharmaceutical, and Novartis; speaker's honoraria from Otsuka Pharmaceutical, Eli Lilly, Shionogi, Pfizer, Yoshitomi Yakuhin, Dainippon-Sumitomo Pharma, Meiji-Seika Pharma, MSD, and Janssen Pharmaceutical; and advisory panel payments from Dainippon-Sumitomo Pharma within the past 3 years. ",

year = "2019",

month = sep,

doi = "10.1016/j.psychres.2018.12.061",

language = "English",

volume = "279",

pages = "372--373",

journal = "Psychiatry Research",

issn = "0165-1781",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Mortality from sepsis among patients with schizophrenia and mood disorders in an intensive care unit

T2 - A chart review

AU - Ishida, Takuto

AU - Nakamura, Kazuha

AU - Miyazaki, Kazuki

AU - Yukawa, Takahiro

AU - Yamagishi, Toshinobu

AU - Sugiyama, Kazuhiro

AU - Tanabe, Takahiro

AU - Hamabe, Yuichi

AU - Mimura, Masaru

AU - Suzuki, Takefumi

AU - Uchida, Hiroyuki

N1 - Funding Information: Dr. Uchida has received grants from Eisai, Otsuka Pharmaceutical, Dainippon-Sumitomo Pharma, Mochida Pharmaceutical, Meiji-Seika Pharmaceutical, and Novartis; speaker's honoraria from Otsuka Pharmaceutical, Eli Lilly, Shionogi, Pfizer, Yoshitomi Yakuhin, Dainippon-Sumitomo Pharma, Meiji-Seika Pharma, MSD, and Janssen Pharmaceutical; and advisory panel payments from Dainippon-Sumitomo Pharma within the past 3 years.

PY - 2019/9

Y1 - 2019/9

UR - http://www.scopus.com/inward/record.url?scp=85071048923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071048923&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2018.12.061

DO - 10.1016/j.psychres.2018.12.061

M3 - Letter

C2 - 30558820

AN - SCOPUS:85071048923

SN - 0165-1781

VL - 279

SP - 372

EP - 373

JO - Psychiatry Research

JF - Psychiatry Research

ER -

Mortality from sepsis among patients with schizophrenia and mood disorders in an intensive care unit: A chart review

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this